Structural insights into the mechanisms of action of functionally distinct classes of Chikungunya virus nonstructural protein 1 inhibitors

Kovacikova, K.; Gonzalez, M.G.; Jones, R.; Reguera, J.; Gigante, A.; Perez-Perez, M.J.; ... ; Hemert, M.J. van (2021)

Article / Letter to editor

Chikungunya virus (CHIKV) nonstructural protein 1 (nsP1) harbors the methyltransferase (MTase) and guanylyltransferase (GTase) activities needed for viral RNA capping and represents a promising antiviral drug target. We compared the antiviral efficacies of nsP1 inhibitors belonging to the MADTP, CHVB, and FHNA series (6'-fluoro-homoneplanocin A [FHNA], its 3'-keto form, and 6'-beta-fluoro-homoaristeromycin). Cell-based phenotypic cross-resistance assays revealed that the CHVB and MADTP series had similar modes of action that differed from that of the FHNA series. In biochemical assays with purified Semliki Forest virus and CHIKV nsP1, CHVB compounds strongly inhibited MTase and GTase activities, while MADTP-372 had a moderate inhibitory effect. FHNA did not directly inhibit the enzymatic activity of CHIKV nsP1. The first-of-their-kind molecular-docking studies with the cryo-electron microscopy (cryo-EM) structure of CHIKV nsP1, which is assembled into a dodecameric ring, revealed that the MADTP and CHVB series bind at the S-adenosylmethionine (SAM)-binding site in the capping domain, where they would function as competitive or noncompetitive inhibitors. The FHNA series was predicted to bind at the secondary binding pocket in the ring-aperture membrane-binding and oligomerization (RAMBO) domain, potentially interfering with the membrane binding and oligomerization of nsP1. Our cell-based and enzymatic assays, in combination with molecular docking and mapping of compound resistance mutations to the nsP1 structure, allowed us to group nsP1 inhibitors into functionally distinct classes. This study identified druggable pockets in the nsP1 dodecameric structure and provides a basis for the rational design, optimization, and combination of inhibitors of this unique and promising antiviral drug target.

• Chikungunya virus
• antivirals
• nsP1
• capping
• resistance
• molecular docking
• SAM
• GTP
• binding pocket
• inhibitors

• All authors: Kovacikova, K.; Gonzalez, M.G.; Jones, R.; Reguera, J.; Gigante, A.; Perez-Perez, M.J.; Purstinger, G.; Moesslacher, J.; Langer, T.; Jeong, L.S.; Delang, L.; Neyts, J.; Snijder, E.J.; Westen, G.J.P. van; Hemert, M.J. van
• Date: 2021-07-01
• Journal: Antimicrobial Agents and Chemotherapy
• Volume: 65
• Issue: 7
• DOI: doi:10.1128/AAC.02566-20
• Link: https://journals.asm.org/doi/10.1128/AAC.02566-20